rotate-mobile
Martedì, 30 Aprile 2024
Salute

Hovione Announces Successful End-of-phase 2 Meeting With the FDA and Outlines Phase 3 Program for Minocycline Topical Gel



In Evidenza

Potrebbe interessarti

Hovione Announces Successful End-of-phase 2 Meeting With the FDA and Outlines Phase 3 Program for Minocycline Topical Gel

Today è in caricamento